The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
This year’s summit, developed in collaboration with the TGA, dived into key issues surrounding prescription medicines, both pre- and post-marketing application processes, and the unique challenges faced by industry/the sector.
- Session 1 - Priority Designation Workshop
- Session 2 - Collaboration and expedited regulatory pathways
- Session 3 - Navigating evaluation issues and common deficiencies
- Session 4 - ICH Q12:Tools and enablers
- Session 5 - Navigating evaluation issues and common deficiencies
- Session 6 - Reforms on the horizon - Prescription medicines registration